Veracyte (VCYT) Tops Q2 EPS by 5c, Revenues Beat; Raises FY19 Revenue Guidance
Tweet Send to a Friend
Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.05), $0.05 better than the analyst estimate of ($0.10). Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
